Clinical Trial Update: Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of recombinant human TSH (rhTSH) as adjuvant radioiodine ablation therapy in differentiated thy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• rhTSH (recombinant human thyroid-stimulating hormone)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Differentiated Thyroid Cancer | Phase 3 | Status: UNKNOWN